Influence of tapentadol and oxycodone on the spinal cord and brain using electrophysiology: a randomized, placebo-controlled trial.

Publication Year: 2022

DOI:
10.1111/bcp.15453

PMCID:
PMC9796052

PMID:
35776835

Journal Information

Full Title: Br J Clin Pharmacol

Abbreviation: Br J Clin Pharmacol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"COMPETING INTERESTS There are no conflicts of interest to declare."

Evidence found in paper:

"Funding information Grünenthal GmbH; Kræftens Bekæmpelse"

Evidence found in paper:

"The study was carried out at Mech‐Sense, Department of Gastroenterology and Hepatology, Aalborg University Hospital, Aalborg, Denmark. Participants gave written, informed consent before participating in the study and were free to withdraw from the study at any time. The study was approved by The North Denmark Region Committee on Health Research Ethics (N‐20170009) and the Danish Medicines Agency, registered at www.clinicaltrialsregister.eu (EudraCT number: 2017‐000141‐52), monitored by the Good Clinical Practice unit at Aalborg and Aarhus University Hospitals, Denmark, and conducted according to the Declaration of Helsinki. Data in this present study is a subset of a larger study with the main objectives to investigate the effects of tapentadol and oxycodone on the central, autonomic and enteric nervous systems. Other data based on this trial are available in Refs , , , , ."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025